<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">In aggregate, these new technologies and approaches could save 2 months in the timeline from lead identification to establishment of a clonally derived cell line suitable for phase 1 production (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>). If toxicology studies are shortened, chemistry, manufacturing and control (CMC) activities may comprise the critical path to the IND filing.
</p>
